Mgr. Jarmila Herůdková, Ph.D.

Researcher, Petr Vaňhara Research Group: Tissue plasticity and regeneration

Correspondence Address:
Kamenice 753/5, 625 00 Brno

Office: bldg. F01B1/225
Kamenice 126/3
625 00 Brno

Phone:	+420 549 49 5589
E‑mail:

Basic information

Supervision

Qualifications

Publications

Type

Total number of publications: 27

2013

Combined treatment of PPARgamma ligand with oxaliplatin affect the cell cycle and death in colon cell line both sensitive and resistant to oxaliplatin

STRAKOVÁ Nicol HOFMANOVÁ Jiřina ZAPLETAL Ondřej SOUČEK Karel FEDR Radek BOUCHAL Jan EHRMANN Jiří KOLÁŘ Zdeněk HYRŠLOVÁ VACULOVÁ Alena TYLICHOVÁ Zuzana LAUKOVÁ Jarmila KOZUBÍK Alois

Conference abstract

Year: 2013, type: Conference abstract
Oxaliplatin with PPARg ligand modulate regulation of the cell cycle and cell death of colon tumors

STRAKOVÁ Nicol HOFMANOVÁ Jiřina SOUČEK Karel FEDR Radek HYRŠLOVÁ VACULOVÁ Alena ZAPLETAL Ondřej TYLICHOVÁ Zuzana LAUKOVÁ Jarmila BOUCHAL Jan EHRMANN Jiří KOLÁŘ Zdeněk KOZUBÍK Alois

Conference abstract

Year: 2013, type: Conference abstract
Rosiglitazone acts as an efficient modulator of LA-12-induced cytotoxic and cytostatic response of colon cancer cells.

LAUKOVÁ Jarmila JELÍNKOVÁ Iva HOFMANOVÁ Jiřina STRAKOVÁ Nicol SOVA Petr EHRMANN Jiří KOLÁŘ Zdeněk KOZUBÍK Alois HYRŠLOVÁ VACULOVÁ Alena

Conference abstract

Year: 2013, type: Conference abstract
Rosiglitazone efficiently sensitizes human colon cancer cells to LA-12-induced apoptosis

LAUKOVÁ Jarmila JELÍNKOVÁ Iva HOFMANOVÁ Jiřina SOVA Petr KOZUBÍK Alois HYRŠLOVÁ VACULOVÁ Alena

Conference abstract

Year: 2013, type: Conference abstract
Rosiglitazone-mediated stimulation of LA-12-induced apoptosis is accompanied by changes in colon cancer cell cycle progression.

LAUKOVÁ Jarmila HOFMANOVÁ Jiřina SOVA Petr STRAKOVÁ Nicol EHRMANN Jiří KOLÁŘ Zdeněk KOZUBÍK Alois HYRŠLOVÁ VACULOVÁ Alena

Conference abstract

Year: 2013, type: Conference abstract
The novel combination of rosiglitazone and platinum (IV) compound LA-12 exerts cooperative cytotoxic effects in colon cancer cells associated with activation of mitochondrial apoptotic pathway.

LAUKOVÁ Jarmila JELÍNKOVÁ Iva HOFMANOVÁ Jiřina SOVA Petr KOZUBÍK Alois HYRŠLOVÁ VACULOVÁ Alena

Conference abstract

Year: 2013, type: Conference abstract

2012

Rosiglitazone-mediated enhancement of LA-12-induced colon cancer cell apoptosis was associated with stimulation of mitochondrial pathway

LAUKOVÁ Jarmila JELÍNKOVÁ Iva STRAKOVÁ Nicol HOFMANOVÁ Jiřina SOVA Petr KOZUBÍK Alois HYRŠLOVÁ VACULOVÁ Alena

Conference abstract

Year: 2012, type: Conference abstract

Projects

Teaching

10 reasons why you will fall in love with MU

Ask our ambassador

Read about research at MU

Mgr. Jarmila Herůdková, Ph.D.

2013

Combined treatment of PPARgamma ligand with oxaliplatin affect the cell cycle and death in colon cell line both sensitive and resistant to oxaliplatin

Oxaliplatin with PPARg ligand modulate regulation of the cell cycle and cell death of colon tumors

Rosiglitazone acts as an efficient modulator of LA-12-induced cytotoxic and cytostatic response of colon cancer cells.

Rosiglitazone efficiently sensitizes human colon cancer cells to LA-12-induced apoptosis

Rosiglitazone-mediated stimulation of LA-12-induced apoptosis is accompanied by changes in colon cancer cell cycle progression.

The novel combination of rosiglitazone and platinum (IV) compound LA-12 exerts cooperative cytotoxic effects in colon cancer cells associated with activation of mitochondrial apoptotic pathway.

2012

Rosiglitazone-mediated enhancement of LA-12-induced colon cancer cell apoptosis was associated with stimulation of mitochondrial pathway